跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOMORPH - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ZOMORPH
Authorized
STANDARD
ZOMORPH
Ethypharm Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0590497b400625e4
Company
Ethypharm Inc
Type
Standard
Approval Details
Approval Id
0590497b400625e4
Drug Approval Canada Name
ZOMORPH
Product Name
ZOMORPH
Status
Approved
Status Date
2005-07-05
Din
02254204
Drug Class
Human
Dosage Form
Capsule (Sustained-Release)
Route Of Administration
Oral
Schedule
Narcotic (CDSA I)
Ahfs
28:08.08
Atc Original
N02AA01 MORPHINE
Atc Name
n 02 aa 01
Aig Number
0104545010
Company Name
Ethypharm Inc
Company Address
SUITE 1500, 1200 Avenue Mcgill College, Montreal, Quebec, Canada, H3B 4G7
Company Detail Path
/organization/ethypharm-inc
Company Information
Pharmaceutical Company Name
Ethypharm Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
1000 rue de la Gauchetière O bureau 2400
Active Ingredients
MORPHINE SULFATE
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0590497b400625e4
Type
Standard
Back to Health Canada Approvals